Crispr Stem & Therapeutics Ltd.

CST Ltd. is an Israeli-based private company, established in 2018. Our vision Develop an innovative gene and cell therapy for acute myocardial ischemia following acute heart attack to save millions of patients. Mission Add a cardio-protective treatment to the standard of care. The aim of the current project is to prevent or to restrict cardiac scar tissue following acute heart attack and thus to reduce the incidence of heart failure (HF). Our vision is to offer a personalized cell therapy treatment, that will save lives and increase life expectancy following a heart attack.